SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001415889-12-000706
Filing Date
2012-05-15
Accepted
2012-05-15 07:01:08
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 bazi10qmar312012.htm 10-Q 422594
2 ex31-1.htm EX-31.1 13834
3 ex31-2.htm EX-31.2 14062
4 ex32-1.htm EX-32.1 6045
5 ex32-2.htm EX-32.2 6143
  Complete submission text file 0001415889-12-000706.txt   1477314

Data Files

Seq Description Document Type Size
6 bazi-20120331.xml EX-101.INS 125647
7 bazi-20120331.xsd EX-101.SCH 10231
8 bazi-20120331_pre.xml EX-101.PRE 57259
9 bazi-20120331_lab.xml EX-101.LAB 78603
10 bazi-20120331_def.xml EX-101.DEF 5981
11 bazi-20120331_cal.xml EX-101.CAL 27859
Mailing Address 1730 BLAKE STREET, SUITE 305 DENVER CO 80202
Business Address 1730 BLAKE STREET, SUITE 305 DENVER CO 80202 303 316-8577
BAZI INTERNATIONAL, INC. (Filer) CIK: 0001134765 (see all company filings)

IRS No.: 841575085 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32420 | Film No.: 12840983
SIC: 2833 Medicinal Chemicals & Botanical Products